KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to -$26.5 million.

  • CareDx's Cash from Financing Activities fell 196202.53% to -$26.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$81.8 million, marking a year-over-year decrease of 15913.55%. This contributed to the annual value of -$5.6 million for FY2024, which is 8106.46% up from last year.
  • CareDx's Cash from Financing Activities amounted to -$26.5 million in Q3 2025, which was down 196202.53% from -$53.8 million recorded in Q2 2025.
  • CareDx's Cash from Financing Activities' 5-year high stood at $189.2 million during Q1 2021, with a 5-year trough of -$53.8 million in Q2 2025.
  • Moreover, its 5-year median value for Cash from Financing Activities was -$1.1 million (2023), whereas its average is $3.4 million.
  • Per our database at Business Quant, CareDx's Cash from Financing Activities skyrocketed by 2584530.61% in 2021 and then plummeted by 196202.53% in 2025.
  • Quarter analysis of 5 years shows CareDx's Cash from Financing Activities stood at -$834000.0 in 2021, then tumbled by 184.41% to -$2.4 million in 2022, then plummeted by 1033.09% to -$26.9 million in 2023, then soared by 96.64% to -$903000.0 in 2024, then tumbled by 2832.23% to -$26.5 million in 2025.
  • Its Cash from Financing Activities was -$26.5 million in Q3 2025, compared to -$53.8 million in Q2 2025 and -$643000.0 in Q1 2025.